BioLineRx (BLRX) Non Operating Income (2013 - 2026)
BioLineRx's Non Operating Income came in at -$690,000 for the quarter ended Jun 30, 2026, compared with -$1.85 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Non Operating Income (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Non Operating Income of -$257,000; for the year ended Dec 31, 2025, it was $8.08 million, down 56.2% from the prior year.
- Going back by year, Non Operating Income was $18.44 million in the year ended Dec 31, 2024, -$10.82 million in the year ended Dec 31, 2023, $5.67 million in the year ended Dec 31, 2022 and -$1.83 million in the year ended Dec 31, 2021.
- The five-year range for quarterly Non Operating Income is -$7.73 million (the quarter ended Jun 30, 2023) to $7.81 million (the quarter ended Jun 30, 2024).
- Year-over-year, Non Operating Income increased in three of the last four quarters, with growth averaging 31.3%.
- The fastest year-over-year change in Non Operating Income over five years came in the quarter ended Sep 30, 2021 (growth of 141.5%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 79.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | -690,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -690,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 756,000.00 |
| Jun 30, 2024 | 7.81 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 2.97 Mn |
| Sep 30, 2023 | -3.14 Mn |
| Jun 30, 2023 | -7.73 Mn |
| Mar 31, 2023 | -2.92 Mn |
| Dec 31, 2022 | 3.56 Mn |
| Sep 30, 2022 | 389,000.00 |
| Jun 30, 2022 | 458,000.00 |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 2.24 Mn |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | -217,000.00 |
API Access
BioLineRx Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();